# LEGUBETI
> **NDA215040** · New Drug Application · Sponsor: GALEPHAR · Approved 2024-02-13
## Drug
- **FDA Application Number:** NDA215040
- **Application type:** New Drug Application
- **Brand name:** LEGUBETI
- **Generic name:** Acetylcysteine Lysine
- **Active ingredients:** ACETYLCYSTEINE LYSINE
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** GALEPHAR
- **First approval:** 2024-02-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215040)
---
*MORVS · CC0 1.0*